Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2005 Nov 19;331(7526):1202.
doi: 10.1136/bmj.331.7526.1202.

Adjuvant trastuzumab for breast cancer: assessing HER2/neu status incurs more costs for treatment

Malcolm R Kell, Colm P Power
Comment

Adjuvant trastuzumab for breast cancer: assessing HER2/neu status incurs more costs for treatment

Malcolm R Kell et al. BMJ. .
No abstract available

PubMed Disclaimer

Comment on

  • Adjuvant trastuzumab for breast cancer.
    Dent R, Clemons M. Dent R, et al. BMJ. 2005 Nov 5;331(7524):1035-6. doi: 10.1136/bmj.331.7524.1035. BMJ. 2005. PMID: 16269471 Free PMC article. No abstract available.

Similar articles

See all similar articles

Cited by

References

    1. Dent R, Clemons M. Adjuvant trastuzumab for breast cancer. BMJ 2005;331: 1035-6. (5 November.) - PMC - PubMed
    1. Ross JS, Fletcher JA, Linette GP, et al. The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy. Oncologist 2003;8: 307-25. - PubMed
    1. Press MF, Sauter G, Bernstein L, et al. Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin Cancer Res 2005;11: 6598-607. - PubMed